← Back to Search

N/A

BREATHE for COVID-19

N/A
Waitlist Available
Led By Nicole Culos-Reed, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow-up (change from baseline)
Awards & highlights

Study Summary

This trial evaluated a self-management program for people living with long COVID in Alberta.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow-up (change from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up (change from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Emotional well-being subscale score
Fatigue
Fatigue severity (FACIT-F)
+14 more
Other outcome measures
Attendance
Safety (the number and nature of adverse events)
Tolerability (change in momentary rating of fatigue)

Trial Design

1Treatment groups
Experimental Treatment
Group I: BREATHEExperimental Treatment1 Intervention
This is an eight-week intervention involving two sessions per week, hosted virtually on Zoom. The main session is scheduled to last 60 min and the session hosts remain online for an additional 15 minutes to answer individual questions on the management of symptoms and activities that have not been addressed during the main session. The content was developed based on clinical experience, best available evidence for the management of specific symptoms (chronic fatigue, post-exertional malaise, breathing discomfort) in other conditions, including post-viral syndromes, and the current understanding and recommendations for rehabilitation of people living with long COVID. Long COVID can be isolating, and challenges often interfere with everyday lifestyle and socialization. The investigators have incorporated breakout rooms (where the group is divided into two smaller groups based on current activity limitations) to include elements of peer support.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,127 Total Patients Enrolled
12 Trials studying COVID-19
19,038 Patients Enrolled for COVID-19
Nicole Culos-Reed, PhDPrincipal InvestigatorUniversity of Calgary
7 Previous Clinical Trials
4,306 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
BREATHE: Virtual Self-management for Long COVID-19
2022. "BREATHE: Virtual Self-management for Long COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05107440.
~8 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top